SSCRIMED
Healthcare buyerUnderstand SCRIMED quicklyDemo, pilot, or pricing ownerConvert demo interest into a priced pilot pathInvestor, strategic partner, or faith-based clinic sponsorUnderstand SCRIMED's investable and sellable value safely
Demo Center

TrialCore · executable-demo

TrialCore Research Operations Demo

Demonstrate an explainable synthetic eligibility review queue with criteria trace and evidence-gap visibility.

BuyerResearch operations, oncology programs, academic medical centers, and trial networks
AgentTrial Matching Agent
Proof routes3
Exclusions4
Recommended pilot60-Day Governed Automation Pilot

Synthetic scenario

A synthetic research packet is evaluated against review criteria while missing evidence, exclusion flags, and researcher approvals remain explicit.

Run TrialCore workflow demo
01Inspect the synthetic eligibility-review sequence.
02Review criteria trace, missing evidence, and exclusion flags.
03Inspect the deterministic result and validation checks.
04Confirm patient outreach and enrollment claims remain blocked.

Inspectable proof

Workflow, result, governance, and quality evidence remain one click away.

proof route

Workflow result

Eligibility review result fixture, criteria trace, and blocked actions.

Inspect Workflow result

Commercial path

Recommended next step: 60-Day Governed Automation Pilot

Synthetic Pilot Evaluation

$125k-$350k standard; research-network or multi-study scope requires custom pricing.

Research operations, oncology programs, academic medical centers, and trial networks.

No patient outreach, enrollment decision, treatment recommendation, PHI, or production research-record mutation.
  • This is operational screening support, not enrollment approval.
  • Pilot success is evidence-gap clarity, criteria trace, and review throughput.
  • Patient outreach and enrollment require separate research governance and customer authority.
Open recommended pilotStart no-PHI intake
Outcome 01

Eligibility review queue

Screening friction surfaced

Outcome 02

Criteria trace

Evidence gaps structured

Outcome 03

Missing-evidence list

Eligibility rationale made inspectable

Outcome 04

Research review requirements

Research review retained

Governance boundary

Human-reviewed synthetic evaluation only.

  • Research-team review remains required.
  • Synthetic research packet only.
  • Eligibility output is operational screening support, not enrollment approval.
01No patient outreach
02No enrollment decision
03No treatment recommendation
04No production research-record mutation
BriefDownload demo brief

Share the buyer, proof path, outcomes, governance boundaries, and exclusions.

RunRun TrialCore workflow demo

Inspect the current executable synthetic product surface.

PilotCompare pilot programs

Choose a structured engagement with outcomes, inputs, gates, and exclusions.

AcceleratorMap price and pilot path

Use market-aligned packaging before custom buyer work expands.

RequestRequest this evaluation

Start a governed buyer intake without submitting PHI.